Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
about
A novel two mode-acting inhibitor of ABCG2-mediated multidrug transport and resistance in cancer chemotherapyDynamic vs static ABCG2 inhibitors to sensitize drug resistant cancer cellsDiscovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/DoxProteomics and mass spectrometry for cancer biomarker discoveryComparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol.Aberrant overexpression of an epithelial marker, 14-3-3sigma, in a subset of hematological malignancies14-3-3sigma Modulates pancreatic cancer cell survival and invasivenessGenomic and oncoproteomic advances in detection and treatment of colorectal cancerComparative genome-wide screening identifies a conserved doxorubicin repair network that is diploid specific in Saccharomyces cerevisiaeRole of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers.Breast cancer proteomics: a review for clinicians.Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.Proteomic studies in breast cancer (Review).Reversible epigenetic regulation of 14-3-3σ expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1.Prediction of individual response to anticancer therapy: historical and future perspectivesDiscovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693.Downregulation of 14-3-3σ correlates with multistage carcinogenesis and poor prognosis of esophageal squamous cell carcinomaSalinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin.Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment.Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.14-3-3σ regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression.Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotypeDeterminants of 14-3-3σ protein dimerization and function in drug and radiation resistance.Cancer epigenomics: implications of DNA methylation in personalized cancer therapy.14-3-3sigma, the double-edged sword of human cancersEIF3i promotes colon oncogenesis by regulating COX-2 protein synthesis and β-catenin activation.Human ABCG2: structure, function, and its role in multidrug resistance.PAR-5 is a PARty hub in the germline: Multitask proteins in development and disease.Nucleophosmin1 associated with drug resistance and recurrence of bladder cancer.Role of 14-3-3σ in resistance to cisplatin in non-small cell lung cancer cells.Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.Regulation of 14-3-3sigma expression in human thyroid carcinoma is epigenetically regulated by aberrant cytosine methylation.Critical residue that promotes protein dimerization: a story of partially exposed Phe25 in 14-3-3σ.Human Chondrosarcoma Cells Acquire an Epithelial-Like Gene Expression Pattern via an Epigenetic Switch: Evidence for Mesenchymal-Epithelial Transition during Sarcomagenesis.14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.
P2860
Q28475529-02F572E2-0CA6-476E-9233-CAD56EB88B72Q28476445-173E0343-BC97-4438-87A5-E519C8A08EC5Q28477021-8F4020EF-6FF9-4888-8052-B629B90F560EQ28766969-63FDF596-CEF0-4D17-AC7E-1DD927190AFCQ30983379-852BBDA5-CB03-4E4C-AB5E-EBBED21127F7Q33307070-A35CD9E9-69EB-45B1-AFE8-6F081326E2B9Q33388611-493D7302-205B-4A46-BD72-EBF26FB4BE00Q33425477-623247BB-EFB1-42BA-845D-7A86D6FF14F1Q33463362-CD23256D-649C-41D0-9226-3BC51C6E3692Q33735346-5EEF1D6E-5342-413B-A238-E19FC657A61FQ33862872-7FD4AEF1-A38A-4F91-AE09-57327895DB71Q33916098-28689261-3C1C-4705-BA8E-0C7884854A85Q34319634-7B9F34EF-B098-4D54-8EF4-B82B6DB418BEQ34360074-5360065B-FA64-4CE2-AB19-E6E4A12B5D9EQ35024682-3741FE30-1246-4C83-816F-91FA89F8F595Q35143276-1C8C48E1-4E76-4060-94A0-18C34BF1CDD7Q35152011-5B4A76EF-56C3-41F7-9A1B-2F19C82D51A2Q35609552-5926B4B7-29C8-42EA-B8D2-FA4AC94E1237Q36388185-8A236146-6F4D-4BF0-997F-2950562DCEC9Q36465265-7BB588AE-C7F8-40E3-B715-D8560712282AQ37109577-A665D061-4577-4B74-AB5F-33E3F1A960ADQ37131365-A1BABBEE-D4B0-466E-9918-2BD91A51CC17Q37272059-CB51E165-9CBE-45AC-B788-F6698BA29C51Q37399404-299854A6-3854-4878-8BDF-72180E85F95AQ37427444-D5E6AAE6-8229-4A44-BE56-5712056461ABQ37656530-BA29A86D-4426-413A-A254-E099865A3DA4Q38003156-14CF716D-5F2C-46A3-BF5C-EA7E53562B3FQ38140915-1B7B41DD-6032-4073-878E-05A7C59F1F7BQ38985274-0450096B-1118-4D5B-9F3D-BB507A60E578Q39206879-4038D581-7D64-45B0-877A-12678A38F338Q39468169-F69BAB92-FB0E-4648-9A21-086607C63716Q39987850-7A3B433B-A563-475B-9A56-A16728B744E2Q41833397-525DB35C-3CBE-4491-859C-997C81720697Q41908214-374C102E-17FC-4AD4-BF03-975E45F762EFQ51191211-38CA7ED0-2C71-497D-9B1F-161E0F9D1A29
P2860
Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Identification of 14-3-3sigma ...... functional proteomic analysis.
@ast
Identification of 14-3-3sigma ...... functional proteomic analysis.
@en
type
label
Identification of 14-3-3sigma ...... functional proteomic analysis.
@ast
Identification of 14-3-3sigma ...... functional proteomic analysis.
@en
prefLabel
Identification of 14-3-3sigma ...... functional proteomic analysis.
@ast
Identification of 14-3-3sigma ...... functional proteomic analysis.
@en
P2093
P1433
P1476
Identification of 14-3-3sigma ...... functional proteomic analysis.
@en
P2093
Baoguang Han
Hailan Liu
Jian-Ting Zhang
P304
P356
10.1158/0008-5472.CAN-05-3801
P407
P577
2006-03-01T00:00:00Z